Alex Sirois

Alex Sirois

InvestorPlace Contributor

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

Microvast Holdings Is an EV Battery Maker With Too Many Current Unknowns

By Alex Sirois, InvestorPlace Contributor

Investors should avoid MVST stock due to Microvast Holdings' unpredictable future which relies heavily on an increasingly unstable China.

7 Best Biotech Stocks to Buy in 2021 with Huge Upside

By Alex Sirois, InvestorPlace Contributor

Biotech stocks are worth considering. Risk aside, big pharma firms can still produce big pharma returns at the end of the day.

7 Bargain Stocks to Buy Under $5 With the Right Catalysts

By Alex Sirois, InvestorPlace Contributor

The risk in these inexpensive bargain stocks is offset by their upside for investors looking for a little more spice in their portfolio.

Roblox Could Be Dressing Your Future Avatar in Designer Brands

By Alex Sirois, InvestorPlace Contributor

RBLX stock is a strong buy despite what was termed a disappointment. The company is central to an emerging trend with huge potential.

Support.com Isn’t an Investment Grade Stock

By Alex Sirois, InvestorPlace Contributor

Given Support.com's weak Q1 financial results and the waning interest in cryptocurrencies, investors should avoid SPRT stock.

Load More